{"id":"https://genegraph.clinicalgenome.org/r/befd71b6-a7bc-4259-a6f2-59c01f21d890v1.1","type":"EvidenceStrengthAssertion","dc:description":"*ELOVL4* was first reported in relation to autosomal dominant Stargardt disease/macular degeneration in 2001 (PMID: 11138005). Patients presented with phenotypes consistent with dominant Stargardt disease/macular degeneration. \n\nThree variants that have been reported from three publications publications (PMIDs: 11138005, 11726641, and 15557430) are included in this curation. In 5 families from the US or Canada, Zhang et al. (PMID: 11138005) found that affected members with Stargardt-like macular dystrophy (STGD3) or autosomal dominant macular dystrophy had an identical heterozygous founder variant in the last exon of the *ELOVL4* gene, a deletion of 5 nucleotides c.790_794del,  p.(Asn264Leufs*9). The other two variants, a nonsense and a frameshift, are also located in the last exon of ELOVL4. The C-terminal truncating variant in ELOVL4 has been shown to exert a dominant negative effect on wild-type ELOVL4 (PMID: 23509295, 15749821).\n\nThis gene-disease association is also supported by experimental evidence that *ELOVL4* exhibits its highest expression levels in retina tissue (PMID: 15028284). Immunolocalization shows that ELOVL4 is localized to the ER of human photoreceptors (PMID: 15028284). \n\nOf note, biallelic variants in this gene have been reported in individuals with ichthyosis, spastic quadriplegia, and intellectual disability (PMID: 24571530, 33652762). This gene-disease relationship will be evaluated separately. \n\nIn summary, *ELOVL4* is definitively associated with autosomal dominant inheritance of *ELOVL4*-related maculopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time without the emergence of contradictory evidence, leading to a Definitive classification according to the ClinGen template. This classification was approved by the ClinGen Retina GCEP on February 2, 2023. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/befd71b6-a7bc-4259-a6f2-59c01f21d890","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9b9daf74-594d-4f11-b322-d671266ebf8e","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9b9daf74-594d-4f11-b322-d671266ebf8e_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2024-06-29T00:38:16.847Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/9b9daf74-594d-4f11-b322-d671266ebf8e_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2023-02-02T17:00:00.000Z","role":"Approver"}],"curationReasonDescription":"replicated over time","curationReasons":["DiseaseNameUpdate"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b9daf74-594d-4f11-b322-d671266ebf8e_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b9daf74-594d-4f11-b322-d671266ebf8e_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/232912ee-1443-492e-be74-e1416d715a61","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4cdf7250-c9bf-4528-9400-c1514346dbbe","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15028284","rdfs:label":"Subcellular localization of the mutant ELOVL4 ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9b9daf74-594d-4f11-b322-d671266ebf8e_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8afc34ab-19bd-4d31-acb6-5190d4b8fa3c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5cad3496-a60a-4125-8cc8-ab953d04187d","type":"Finding","dc:description":"fundus images also show that the deterioration of the retina is localized, as found in patients with a severe form of dry AMD, called “geographical atrophy.”  Abnormalities in fundus appearance related to the expression level of the mutant ELOVL4; higher level of expression resulted in a more abnormal fundus. Nevertheless, even the TG1 mice, with less expression of the mutant ELOVL4 than of the normal endogenous Elovl4, underwent retinal deterioration, with subretinal deposits similar to retinal flecks seen in patients with STGD","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15749821","rdfs:label":"transgenic mice ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/9b9daf74-594d-4f11-b322-d671266ebf8e_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/903c97d9-f072-4f8a-9ac2-0af9175131d8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/903c97d9-f072-4f8a-9ac2-0af9175131d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f6b1283-fd9f-4c1c-973c-0f1afa5acb66","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022726.4(ELOVL4):c.790_794del (p.Asn264LeufsTer9)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA645372824"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/903c97d9-f072-4f8a-9ac2-0af9175131d8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"loss of a C-terminal ER targeting signal and abnormal localization of the ELOVL4 protein from the ER to the Golgi following transfection into COS-7 cells","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f954602b-450e-490c-ba11-d5007dea3779","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f954602b-450e-490c-ba11-d5007dea3779_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f6b1283-fd9f-4c1c-973c-0f1afa5acb66"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f954602b-450e-490c-ba11-d5007dea3779_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"loss of a C-terminal ER targeting signal and abnormal localization of the ELOVL4 protein from the ER to the Golgi following transfection into COS-7 cells","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/425c96be-a826-470c-9936-d243fb113690","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/425c96be-a826-470c-9936-d243fb113690_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15557430","allele":{"id":"https://genegraph.clinicalgenome.org/r/84ab6cf1-e891-4023-89f7-c43cbc3832f9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022726.4(ELOVL4):c.810C>G (p.Tyr270Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117148"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/425c96be-a826-470c-9936-d243fb113690_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"subcellular localization studies showed that, unlike wild-type ELOVL4, the mutant does not localize to the ER. The mislocalized protein seems to be sequestered in another subcellular compartment exhibiting dense fluorescence-positive aggregates","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4a2234ef-bb57-4dc5-8af3-d70763dc875d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a2234ef-bb57-4dc5-8af3-d70763dc875d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f6b1283-fd9f-4c1c-973c-0f1afa5acb66"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/4a2234ef-bb57-4dc5-8af3-d70763dc875d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"loss of a C-terminal ER targeting signal and abnormal localization of the ELOVL4 protein from the ER to the Golgi following transfection into COS-7 cells","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/29cce225-c5b0-429d-8410-19e7b8cc7db7","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29cce225-c5b0-429d-8410-19e7b8cc7db7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f6b1283-fd9f-4c1c-973c-0f1afa5acb66"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/29cce225-c5b0-429d-8410-19e7b8cc7db7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"loss of a C-terminal ER targeting signal and abnormal localization of the ELOVL4 protein from the ER to the Golgi following transfection into COS-7 cells","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9b9daf74-594d-4f11-b322-d671266ebf8e_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a998a9e7-e993-413e-8c26-ca7d6eaedca9_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","rdfs:label":"family A","estimatedLodScore":13.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/a998a9e7-e993-413e-8c26-ca7d6eaedca9","type":"Family","rdfs:label":"family A"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":26,"publishedLodScore":9.66,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/22ee113c-cc8c-4058-b688-0ece40f3ef8a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","rdfs:label":"family C","estimatedLodScore":5.72,"family":{"id":"https://genegraph.clinicalgenome.org/r/22ee113c-cc8c-4058-b688-0ece40f3ef8a","type":"Family","rdfs:label":"family C","member":{"id":"https://genegraph.clinicalgenome.org/r/17f926a7-03b9-4590-bada-2a9ebbe62692","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","rdfs:label":"FC P1","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f6b1283-fd9f-4c1c-973c-0f1afa5acb66"},"previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/903c97d9-f072-4f8a-9ac2-0af9175131d8_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":12,"proband":{"id":"https://genegraph.clinicalgenome.org/r/17f926a7-03b9-4590-bada-2a9ebbe62692"},"publishedLodScore":4.36,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/2651a7cb-4485-435a-a01e-f3bfe978d2f4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","rdfs:label":"family D","estimatedLodScore":6.02,"family":{"id":"https://genegraph.clinicalgenome.org/r/2651a7cb-4485-435a-a01e-f3bfe978d2f4","type":"Family","rdfs:label":"family D","member":{"id":"https://genegraph.clinicalgenome.org/r/387d43a1-fa01-4b3d-ac42-fa7f140e2784","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","rdfs:label":"FD P1","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f6b1283-fd9f-4c1c-973c-0f1afa5acb66"},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/29cce225-c5b0-429d-8410-19e7b8cc7db7_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":11,"proband":{"id":"https://genegraph.clinicalgenome.org/r/387d43a1-fa01-4b3d-ac42-fa7f140e2784"},"publishedLodScore":4.42,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/fedf918c-cc49-4c96-b2a5-b6f3c1ca078f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","rdfs:label":"UM:H785","estimatedLodScore":11.74,"family":{"id":"https://genegraph.clinicalgenome.org/r/fedf918c-cc49-4c96-b2a5-b6f3c1ca078f","type":"Family","rdfs:label":"UM:H785","member":{"id":"https://genegraph.clinicalgenome.org/r/0d0268d9-ae66-40d2-ba61-c75a8deb1889","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","rdfs:label":"UM:H785 P1","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f6b1283-fd9f-4c1c-973c-0f1afa5acb66"},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f954602b-450e-490c-ba11-d5007dea3779_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":16,"proband":{"id":"https://genegraph.clinicalgenome.org/r/0d0268d9-ae66-40d2-ba61-c75a8deb1889"},"publishedLodScore":3.5,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/f678f0b4-30f8-41f3-839a-5cd4e38138dd_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11726641","rdfs:label":"K4175","estimatedLodScore":7.53,"family":{"id":"https://genegraph.clinicalgenome.org/r/f678f0b4-30f8-41f3-839a-5cd4e38138dd","type":"Family","rdfs:label":"K4175"},"meetsInclusionCriteria":true,"phenotype":[{"id":"obo:HP_0000006"},{"id":"obo:HP_0007963"},{"id":"obo:HP_0007754"},{"id":"obo:HP_0000622"},{"id":"obo:HP_0011504"}],"phenotypeFreeText":"phenotypes of family members ranged from STGD3 to butterfly-pattern dystrophy to bull’s-eye maculopathy","phenotypePositiveAllelePositive":12,"publishedLodScore":3.86,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/add9523e-dc4f-4dc1-a335-258417381f9b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15557430","rdfs:label":"F1","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/add9523e-dc4f-4dc1-a335-258417381f9b","type":"Family","rdfs:label":"F1","member":{"id":"https://genegraph.clinicalgenome.org/r/3cdf8b46-01cc-413d-ac52-6a9675ec23c5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15557430","rdfs:label":"III:2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/84ab6cf1-e891-4023-89f7-c43cbc3832f9"},"detectionMethod":"direct sequence analysis of all six exons and flanking splice sites of the ELOVL4 gene\n\nThe identified novel ELOVL4 mutation was tested on a panel of 96 ethnically matched control individuals, using an amplification-refractory mutation specific (ARMS) technique. ","firstTestingMethod":"Sanger sequencing","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/425c96be-a826-470c-9936-d243fb113690_variant_evidence_item"}}},"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/3cdf8b46-01cc-413d-ac52-6a9675ec23c5"}},{"id":"https://genegraph.clinicalgenome.org/r/45ac5e1d-c4c3-49ea-957a-86fdf9cd4a42_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","rdfs:label":"STGD3/Canadian family","estimatedLodScore":6.92,"family":{"id":"https://genegraph.clinicalgenome.org/r/45ac5e1d-c4c3-49ea-957a-86fdf9cd4a42","type":"Family","rdfs:label":"STGD3/Canadian family","member":{"id":"https://genegraph.clinicalgenome.org/r/8bc68ee1-18db-41ff-b457-72ac0eef105a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11138005","rdfs:label":"STGD/CAN F P1","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f6b1283-fd9f-4c1c-973c-0f1afa5acb66"},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/4a2234ef-bb57-4dc5-8af3-d70763dc875d_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":11,"proband":{"id":"https://genegraph.clinicalgenome.org/r/8bc68ee1-18db-41ff-b457-72ac0eef105a"},"publishedLodScore":3.34,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.5}],"evidenceStrength":"Definitive","sequence":8573,"specifiedBy":"GeneValidityCriteria9","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/m3dug9Zapgw","type":"GeneValidityProposition","disease":"obo:MONDO_0700227","gene":"hgnc:14415","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9b9daf74-594d-4f11-b322-d671266ebf8e-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}